1. Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database.
- Author
-
Jacob J, Alexander D, Baillie JK, Berka R, Bertolli O, Blackwood J, Buchan I, Bloomfield C, Cushnan D, Docherty A, Edey A, Favaro A, Gleeson F, Halling-Brown M, Hare S, Jefferson E, Johnstone A, Kirby M, McStay R, Nair A, Openshaw PJM, Parker G, Reilly G, Robinson G, Roditi G, Rodrigues JCL, Sebire N, Semple MG, Sudlow C, Woznitza N, and Joshi I
- Subjects
- COVID-19, Communicable Diseases, Emerging diagnostic imaging, Coronavirus Infections epidemiology, Databases, Factual statistics & numerical data, Diagnostic Imaging methods, Diagnostic Imaging statistics & numerical data, Female, Humans, Male, Pneumonia, Viral epidemiology, Program Development, Radiography, Thoracic methods, Radiography, Thoracic statistics & numerical data, Tomography, X-Ray Computed methods, United Kingdom, Artificial Intelligence statistics & numerical data, Communicable Diseases, Emerging epidemiology, Coronavirus Infections diagnostic imaging, Pandemics statistics & numerical data, Pneumonia, Viral diagnostic imaging, Tomography, X-Ray Computed statistics & numerical data
- Abstract
Competing Interests: Conflict of interest: J. Jacob reports fees from Boehringer Ingelheim and Roche unrelated to the current submission and is supported by a Clinical Research Career Development Fellowship 209553/Z/17/Z from the Wellcome Trust, and by the NIHR Biomedical Research Centre at University College London. Conflict of interest: D. Alexander has nothing to disclose. Conflict of interest: J.K. Baillie reports grants from DHSC National Institute of Health Research UK, Medical Research Council UK, Wellcome Trust, Fiona Elizabeth Agnew Trust, Intensive Care Society and Chief Scientist Office, during the conduct of the study. Conflict of interest: R. Berka is an Associate at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. Conflict of interest: O. Bertolli is an Associate at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. Conflict of interest: J. Blackwood has nothing to disclose. Conflict of interest: I. Buchan reports personal fees from and acting as advisor for AstraZeneca, grants from NIHR, and is a former employee of Microsoft, outside the submitted work. Conflict of interest: C. Bloomfield reports that NCIMI is funded through support from the Industry Strategy Challenge Fund, by Innovate UK grant 104688. Conflict of interest: D. Cushnan has nothing to disclose. Conflict of interest: A. Docherty has nothing to disclose. Conflict of interest: A. Edey has nothing to disclose. Conflict of interest: A. Favaro is a Lead Data Scientist at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. Conflict of interest: F. Gleeson has nothing to disclose. Conflict of interest: M. Halling-Brown is an advisor to Google Health on the MAMMOTH project, and has a Visiting Professorship with University of Surrey as part of a research collaboration with Transpara. Conflict of interest: S. Hare has nothing to disclose. Conflict of interest: E. Jefferson reports grants from Medical Research Council (MRC), Health Data Research (HDR) UK, National Institute of Health Research (NIHR), Chief Scientist Office (CSO), Engineering and Physical Sciences Research Council (EPSRC), Health Foundation, Data Lab, Scottish Government, NHS Fife Health Board and EU Horizon 2020, during the conduct of the study. Conflict of interest: A. Johnstone has nothing to disclose. Conflict of interest: M. Kirby is a Principal at Faculty; Faculty has a paid partnership with NHSX to build its new AI lab to help drive digital transformation and the use of AI in the NHS. This contract has been extended for setting up the platform environment that manages the data storage for the National COVID-19 Chest Imaging Database (NCCID); the platform is being made available by Faculty at zero licence cost. In addition, Faculty is contracted to support NHS England and Improvement as well as NHSX with its data response strategy to COVID-19, which includes developing dashboards, models and simulations to provide information to central government decision-makers. Conflict of interest: R. McStay has nothing to disclose. Conflict of interest: A. Nair reports salary reimbursement from Biomedical Research Centre UCL, and is medical advisor to Aidence BV, outside the submitted work. Conflict of interest: P.J.M. Openshaw reports personal fees for consultancy work with Janssen, J and J and Sanofi; grants from MRC, European Union, NIHR Biomedical Research Centre and Wellcome Trust, collaborative grants with GSK, personal fees from the European Respiratory Society and an NIHR Senior Investigator Award outside the submitted work; in addition, P.J.M. Openshaw was President of the British Society for Immunology; this was an unpaid appointment but travel and accommodation at some meetings was provided by the Society. Conflict of interest: G. Parker is director and shareholder of Bioxydyn Limited, outside the submitted work. Conflict of interest: G. Reilly has nothing to disclose. Conflict of interest: G. Robinson has nothing to disclose. Conflict of interest: G. Roditi has nothing to disclose. Conflict of interest: J.C.L. Rodrigues has nothing to disclose. Conflict of interest: N. Sebire has nothing to disclose. Conflict of interest: M.G. Semple reports grants from DHSC National Institute of Health Research UK, Medical Research Council UK, Health Protection Research Unit in Emerging and Zoonotic Infections, and University of Liverpool, during the conduct of the study; and is minority owner of Integrum Scientific LLC, Greensboro, NC, USA, outside the submitted work. Conflict of interest: C. Sudlow has nothing to disclose. Conflict of interest: N. Woznitza reports grants from Cancer Research UK and Roy Castle Lung Cancer Foundation, personal fees from InHealth, outside the submitted work. Conflict of interest: I. Joshi has nothing to disclose.
- Published
- 2020
- Full Text
- View/download PDF